Back
BMO NASDAQ 100 Equity ETF (USD Units) Vs. Agios Pharmaceuticals Industry Stock Comparison
Buy
82
ZNQ.U.TO
BMO NASDAQ 100 Equity ETF (USD Units)
Last Price:
47.45
Seasonality Move:
-1.31%
Sell
1
AGIO
Agios Pharmaceuticals
Last Price:
38.94
Seasonality Move:
12.89%
Buy
82
BMO NASDAQ 100 Equity ETF (USD Units) (ZNQ.U.TO)
is a Buy
Is BMO NASDAQ 100 Equity ETF (USD Units) a Buy, Sell or Hold?
- The current BMO NASDAQ 100 Equity ETF (USD Units) [ZNQ.U.TO] share price is $47.29. The Score for ZNQ.U.TO is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- ZNQ.U.TO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
1
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $38.17. The Score for AGIO is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- AGIO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ZNQ.U.TO Stock Price Chart
What is BMO NASDAQ 100 Equity ETF (USD Units)'s stock price today?
-
The BMO NASDAQ 100 Equity ETF (USD Units) share price today is $47.29
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZNQ.U.TO is experiencing slight selling pressure.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $38.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGIO is experiencing selling pressure, which indicates risk of future bearish movement.
ZNQ.U.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.63 | Buy |
Relative Strength Index (14 RSI): | 70.46 | Buy |
Chaikin Money Flow: | -56 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.12 - 46.7) | Buy |
Bollinger Bands (100): | (41.67 - 45.43) | Buy |
AGIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.34 | Sell |
Relative Strength Index (14 RSI): | 26.34 | Sell |
Chaikin Money Flow: | -1550643 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.73 - 60.93) | Sell |
Bollinger Bands (100): | (42.01 - 53.19) | Sell |
ZNQ.U.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.89 | Buy |
20-day SMA: | 45.92 | Buy |
50-day SMA: | 45.04 | Buy |
200-day SMA: | 42.12 | Buy |
8-day EMA: | 46.8 | Buy |
20-day EMA: | 46.18 | Buy |
50-day EMA: | 45.17 | Buy |
200-day EMA: | 42.03 | Buy |
AGIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 51.89 | Sell |
20-day SMA: | 54.55 | Sell |
50-day SMA: | 49.66 | Sell |
200-day SMA: | 41.9 | Sell |
8-day EMA: | 48.9 | Sell |
20-day EMA: | 52.35 | Sell |
50-day EMA: | 50.92 | Sell |
200-day EMA: | 42.82 | Sell |
BMO NASDAQ 100 Equity ETF (USD Units) Earnings Growth & ZNQ.U.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $9.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.46 per share, and a decrease next year of $16.90 per share.
BMO NASDAQ 100 Equity ETF (USD Units) Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Agios Pharmaceuticals Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |